Now Approved: First Approved Topical Treatment Indicated for Persistent Facial Erythema of Rosacea
First Approved Topical Treatment Indicated for Persistent Facial Erythema of Rosacea Let’s face it, rosacea can be downright embarrassing at times. It can cause reddened cheeks that can cause individuals to not want to go out in public at times. But there may be new hope. A new medication is now available that shows promise in treating these specific symptoms. Mirvaso (brimonidine) topical gel, 0.33% was approved by the United States Food and Drug Administration on August...